Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle
NCT01024218 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2017-02-24
Summary
This trial is conducted in Europe. The aim of this clinical trial is to assess the preference of 2 different needles used by nurses and health assistants. The trial consists of a handling test followed by a 12 week cross-over study.
Conditions
- Diabetes
- Healthcare Professionals
- Delivery Systems
Interventions
- DEVICE
-
NovoFine® needle 8 mm
- DEVICE
-
autocover needle
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-01
- Primary Completion
- 2005-04-26
- Completion
- 2005-04-26
Countries
- Denmark
Study Locations
More Related Trials
-
Comparison of Glycemic Control Achieved With 2 Different Needles
NCT00572052 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Experiences With Injection Needles
NCT02531776 ·Status: COMPLETED ·Phase: NA
-
Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles
NCT01231984 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
NCT02690467 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles
NCT00928057 ·Status: COMPLETED ·Phase: NA
-
Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
NCT01680328 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle
NCT03267264 ·Status: COMPLETED ·Phase: NA
-
Which Needle Length for Injecting Insulin
NCT00292890 ·Status: COMPLETED ·Phase: NA
-
A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes
NCT01730014 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia
NCT00760448 ·Status: COMPLETED ·Phase: PHASE1
-
Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe
NCT00127296 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.
NCT02103595 ·Status: COMPLETED ·Phase: NA
-
A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®
NCT02627287 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Without a Skin Fold and Inserted at Either 45 or 90 Degrees
NCT00894270 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously
NCT01061216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.
NCT01745549 ·Status: COMPLETED ·Phase: NA
-
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
NCT01486940 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units
NCT01334606 ·Status: TERMINATED ·Phase: NA
-
Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
NCT00453934 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Evaluation of BD NEXT Pen Needle
NCT01852136 ·Status: COMPLETED
-
Changes of the Infusion Rate in Insulin Pump Treatment
NCT00449839 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
NCT03220425 ·Status: COMPLETED ·Phase: PHASE3
-
Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose
NCT04460092 ·Status: UNKNOWN ·Phase: NA
-
A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes
NCT01030926 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
NCT06685185 ·Status: COMPLETED ·Phase: PHASE1